2 Nuclear Stocks Worth Owning for the Entire Year as Power Demand Keeps Climbing

The article is constructive on Cameco and Oklo, arguing that rising uranium prices and growing nuclear demand could support both stocks. Cameco mined 15% of global uranium in 2025, with analysts seeing uranium prices reaching $100-$125 per pound and revenue/EBITDA CAGR of 8% and 12% from 2025-2028. Oklo is highlighted as a higher-risk next-gen reactor play, with its first 75 MW Aurora Powerhouse targeted for 2027 and revenue projected to rise from under $1 million to $36 million by 2028.

Analysis

The cleanest read-through is that this is less a “nuclear trade” than a duration trade on constrained physical supply versus long-cycle capacity additions. In the near term, the lever is uranium pricing power: upstream names with inventory discipline and unhedged exposure should continue to outperform as utilities rebuild coverage, while any producer with fixed-price legacy contracts is a relative laggard. The second-order winner is the fuel-cycle complex: enrichment, conversion, and services should re-rate before new reactor deployments meaningfully move earnings, because the bottleneck is not generation capacity but reliable fuel processing and permitting.

Oklo is the higher-beta expression of an optionality trade, but the market is likely over-discounting the timing gap between headline contracts and revenue realization. The key issue is not whether microreactors are theoretically attractive; it is whether deployment economics survive regulatory drag, siting friction, and customer willingness to prepay for unproven hardware. That creates a binary setup: if the first projects hit schedule, valuation can compress quickly by 2027-2028; if not, the stock remains a financing vehicle rather than a cash-flow story.

The contrarian risk on the whole basket is that AI-driven electricity demand can be met faster and cheaper by gas peakers, grid upgrades, and large-scale renewables plus storage before nuclear scales. If power demand growth normalizes or uranium spot rolls over, the equity tape could unwind quickly because the stocks are pricing a multi-year scarcity regime, not just a one-year commodity spike. The biggest missing piece in consensus is that “more nuclear” does not automatically mean “more reactor vendors win”; incumbent fuel suppliers and infrastructure owners may capture the first and most reliable economics, while developers stay option-like for longer than bulls expect.

Key Decisions for Investors

• Long CCJ vs. short a diversified clean-power basket for 6-12 months: the setup favors physical uranium leverage over asset-heavy generation names; target 15-20% upside if spot remains firm, with risk defined by a pullback in utility contracting.
• Buy call spreads on CCJ into any commodity pullback, using 9-12 month maturities: the risk/reward is better than stock because the thesis depends on persistent price strength, not linear earnings growth.
• Treat OKLO as a venture-style position only: initiate small, if at all, via limited-risk calls or a sub-1% equity weighting into catalyst windows (regulatory milestones, project updates), because the main risk is dilution before revenue inflects.
• Pair long CCJ / short OKLO for a cleaner expression of the thesis: this captures near-term monetization of nuclear demand while hedging the execution and financing risk embedded in microreactors.
• Monitor enrichment and services names as the next leg: if uranium stays tight for 2+ quarters, rotate into the fuel-cycle beneficiaries before reactor builders, since that is where margins should expand first.